SCHEMBL5547366

SCHEMBL5547366

NC(=O)CO[CH]c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
HTT P42858 2/20 0.44
ALDH1A1 P00352 3/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 1/20 0.40
MAPT P10636 2/20 0.40
PKM P14618 2/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PAM P19021 1/20 0.38
MCL1 Q07820 1/20 0.38
PLA2G7 Q13093 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.38
HDAC3 O15379 1/20 0.38
TNKS O95271 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3300954 0.83 ALOX15 (0.48) ALDH1A1L3MBTL1SMN1; SMN2MAPTCYP1A2
SCHEMBL7384196 0.77 POLB (0.43) KDM4EALDH1A1L3MBTL1SMN1; SMN2MAPT
SCHEMBL535167 0.74 GABBR2 (0.40) SMN1; SMN2PKMPAMKMT2A
SCHEMBL4992922 0.73 KDM4E (0.42) KDM4EHTTALDH1A1GAAL3MBTL1
SCHEMBL7017014 0.73 HCAR2 (0.35) ALDH1A1PKMHCAR2
SCHEMBL5727816 0.73 PTPN1 (0.38) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL27834761 0.72 MAPT (0.43) KDM4EHTTALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL2363130 0.72 GPR174 (0.38) ALDH1A1GAAL3MBTL1SMN1; SMN2MAPT
SCHEMBL21026012 0.72 ATM (0.56) KDM4EHTTALDH1A1GAASMN1; SMN2
SCHEMBL790911 0.72 ALDH1A1 (0.36) ALDH1A1L3MBTL1SMN1; SMN2MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794162-A1 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health (US) 2007-06-13 EP disclosed
WO-2006031505-A1 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2006-03-23 WO disclosed